Syros Pharmaceuticals, Inc. (SYRS)
Data as of , from SEC Form 4 filings.
See up to 3 months of SYRS. The 7-day demo opens the 1M and 3M ranges and puts SYRS on your watchlist.
Start 7-day demoLatest SYRS insider trades
About Syros Pharmaceuticals, Inc. (SYRS)
Syros Pharmaceuticals, Inc. files with the SEC under CIK 0001556263 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
SYRS Form 4 activity by transaction type, last 90 days
No Form 4 activity for SYRS in the last 90 days.
SYRS insider transactions (Form 4)
2413 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nancy A. Simonian | Open-market sale | Common Stock | 37,070 | $0.27 | $10K | |
| Nancy A. Simonian | Open-market sale | Common Stock | 134,713 | $0.27 | $36K | |
| Kristin Stephens - Officer | Open-market sale | Common Stock | 36,133 | $0.22 | $8K | |
| David Roth - Officer | Open-market sale | Common Stock | 12,099 | $0.20 | $2K | |
| Conley Chee - Officer | Open-market sale | Common Stock | 134,797 | $0.20 | $27K | |
| Jason Haas - Officer | Open-market sale | Common Stock | 137,803 | $0.21 | $29K | |
| Gerald E. Quirk - Officer | Open-market sale | Common Stock | 46,657 | $0.22 | $10K | |
| David Roth - Officer | Option exercise | Common Stock | 18,875 | - | - | |
| David Roth - Officer | Tax withholding / forfeiture | Common Stock | 6,776 | $2.09 | $14K | |
| David Roth - Officer | Option exercise | Restricted Stock Units | 18,875 | $0.00 | - | |
| Jason Haas - Officer | Option exercise | Common Stock | 18,875 | - | - | |
| Jason Haas - Officer | Tax withholding / forfeiture | Common Stock | 5,624 | $2.09 | $12K | |
| Jason Haas - Officer | Option exercise | Restricted Stock Units | 18,875 | $0.00 | - | |
| Conley Chee - Officer | Option exercise | Common Stock | 17,000 | - | - | |
| Conley Chee - Officer | Tax withholding / forfeiture | Common Stock | 8,707 | $2.09 | $18K | |
| Conley Chee - Officer | Option exercise | Restricted Stock Units | 17,000 | $0.00 | - | |
| Kristin Stephens - Officer | Option exercise | Common Stock | 17,000 | - | - | |
| Kristin Stephens - Officer | Tax withholding / forfeiture | Common Stock | 6,104 | $2.09 | $13K | |
| Kristin Stephens - Officer | Option exercise | Restricted Stock Units | 17,000 | $0.00 | - | |
| Nancy A. Simonian | Option exercise | Common Stock | 40,125 | - | - | |
| Nancy A. Simonian | Option exercise | Restricted Stock Units | 40,125 | $0.00 | - | |
| Gerald E. Quirk - Officer | Option exercise | Common Stock | 10,000 | - | - | |
| Gerald E. Quirk - Officer | Tax withholding / forfeiture | Common Stock | 3,100 | $2.10 | $7K | |
| Gerald E. Quirk - Officer | Option exercise | Restricted Stock Units | 10,000 | $0.00 | - |
SYRS insider trading FAQ
What is the latest insider trade for SYRS?
Syros Pharmaceuticals, Inc. (SYRS) has filed no insider reports in the last 90 days. The most recent on record is dated 2024-12-04. The full record for SYRS runs to 13 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SYRS stock?
No insider purchases of SYRS were filed in the last 90 days.
How many insiders are selling SYRS stock?
No insider sales of SYRS were filed in the last 90 days. 7 sales are on record for this company.
Where can I see SYRS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SYRS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Nancy A. Simonian view on EDGAR
- - Nancy A. Simonian view on EDGAR
- - Kristin Stephens view on EDGAR
- - David Roth view on EDGAR
- - Conley Chee view on EDGAR
- - Jason Haas view on EDGAR
- - Gerald E. Quirk view on EDGAR
- - David Roth view on EDGAR
- - Jason Haas
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SYRS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SYRS with a 7-day demo
- SYRS on your watchlist
- Every SYRS Form 4 filing on record
- Up to 3 months of SYRS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
